Login / Signup

Extraskeletal myxoid chondrosarcoma: Clinicopathological features and outcomes from the United States sarcoma collaborative database.

Charles A GushoDavid KingCecilia G EthunKenneth CardonaJ Harrison HowardThuy B TranGeorge PoultsidesJennifer TsengKevin K RogginRyan C FieldsDarren R CullinanKonstantinos ChouliarasKonstantinos VotanopoulosValerie P GrignolMeena Bedi
Published in: Journal of surgical oncology (2022)
Long-term survival with EMC is probable, however there exists a high incidence of locoregional recurrence. While chemotherapy and radiation were associated with a worse RFS, these findings were likely confounded by recurrent disease as significance was lost in the primary EMC-only subset.
Keyphrases
  • risk factors
  • quality improvement
  • locally advanced
  • free survival
  • adverse drug
  • drug induced